Immunotherapy of peritoneal carcinomatosis with catumaxomab

Onkologie. 2011;34(3):86-7. doi: 10.1159/000324793. Epub 2011 Feb 15.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Bispecific / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use*
  • Peritoneal Neoplasms / drug therapy*
  • Stomach Neoplasms / drug therapy*

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal
  • Immunologic Factors
  • catumaxomab